Amylyx Pharmaceuticals, Inc. (AMLX)
33.75
-0.99
(-2.85%)
USD |
NASDAQ |
Aug 31, 16:00
33.35
-0.40
(-1.19%)
After-Hours: 07:17
Amylyx Pharmaceuticals Total Long Term Debt (Quarterly) : 4.247M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.247M |
| March 31, 2026 | 4.476M |
| December 31, 2025 | 4.698M |
| September 30, 2025 | 4.954M |
| June 30, 2025 | 5.297M |
| March 31, 2025 | 0.327M |
| December 31, 2024 | 0.463M |
| September 30, 2024 | 0.595M |
| June 30, 2024 | 0.772M |
| March 31, 2024 | 1.382M |
| December 31, 2023 | 1.98M |
| September 30, 2023 | 2.567M |
| Date | Value |
|---|---|
| June 30, 2023 | 3.141M |
| March 31, 2023 | 3.694M |
| December 31, 2022 | 4.237M |
| September 30, 2022 | 4.768M |
| June 30, 2022 | 5.287M |
| March 31, 2022 | 5.786M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 1.425M |
| September 30, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Pfizer Inc. | 63.10B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |
| EyePoint, Inc. | 19.81M |
| Bristol Myers Squibb Co. | 44.59B |